Preclinical pharmacology, efficacy, and safety of varenicline in smoking cessation and clinical utility in high risk patients
Zheng-Xiong XiNational Institute on Drug Abuse, Intramural Research Program, Baltimore, MD, USAAbstract: Smoking is still the most prominent cause of preventable premature death in the United States and an increasing cause of morbidity and mortality throughout the world. Although the current treatme...
Main Author: | Zheng-Xiong Xi |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-04-01
|
Series: | Drug, Healthcare and Patient Safety |
Online Access: | http://www.dovepress.com/preclinical-pharmacology-efficacy-and-safety-of-varenicline-in-smoking-a4246 |
Similar Items
-
Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation
by: S. R. Gilyarevskiy
Published: (2019-03-01) -
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
by: Jon O Ebbert, et al.
Published: (2010-09-01) -
Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
by: Saeed Ahmed, et al.
Published: (2018-09-01) -
Smoking cessation therapy with varenicline
by: Uma M Mohanasundaram, et al.
Published: (2008-06-01) -
Smoking cessation in Asians: focus on varenicline
by: Xiao D, et al.
Published: (2015-04-01)